|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Novavax (NASDAQ: NVAX) through any online brokerage.
The latest price target for Novavax (NASDAQ: NVAX) was reported by Cowen & Co. on January 21, 2022. The analyst firm set a price target for 150.00 expecting NVAX to rise to within 12 months (a possible 80.90% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Novavax (NASDAQ: NVAX) is $82.92 last updated Fri Jan 28 2022 21:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Novavax.
Novavax’s $Q4 earnings are confirmed for after-market on February 28, 2022.
There is no upcoming split for Novavax.
Novavax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.